Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00075062 · ClinicalTrials.gov registry record
A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 16
- Enrollment target
NCT00075062: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00075062 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00075062 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Microbicides are drugs that destroy microbes such as viruses and bacteria. Rectal microbicides may be able to prevent transmission of HIV during anal intercourse. The purpose of this study is to obtain rectal samples from men to learn information that may be valuable in future clinical trials of rectal microbicides.
Interventions
- PROCEDURE Rectal Biopsy
- PROCEDURE Flexible Sigmoidoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
What the finished NCT00075062 record still lists
NCT00075062 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Rectal Biopsy is the first listed.
NCT00075062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00075062 about?
NCT00075062 is a clinical study titled "A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials". Microbicides are drugs that destroy microbes such as viruses and bacteria. Rectal microbicides may be able to prevent transmission of HIV during anal intercourse. The purpose of this study is to obtain rectal samples from men to learn information that may be valuable in future clinical trials of rec...
What is the current status of trial NCT00075062?
This trial is currently completed. The enrollment target is 16 participants.
What interventions are being tested in trial NCT00075062?
The interventions under investigation include: Rectal Biopsy (PROCEDURE), Flexible Sigmoidoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00075062?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease